2013
DOI: 10.1016/j.ijsu.2013.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary metastasectomy for colorectal cancer: Long-term survival and prognostic factors

Abstract: These results indicate that prognostic factors identified in studies on pulmonary metastasectomy for all primary tumors should be interpreted carefully for patients with possibility of pulmonary metastasectomy from colorectal carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
26
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(26 citation statements)
references
References 24 publications
0
26
0
Order By: Relevance
“…In our series, major postoperative morbidity (Clavein-Dindo grade III) was 4.2% and there was no postoperative mortality, which concurs with other studies. 39,43 In a systematic review, 30-day postoperative mortality ranged from 0% to 2.5%. 9 Thus, Pmet is a safe procedure in carefully selected patients.…”
Section: Discussionmentioning
confidence: 99%
“…In our series, major postoperative morbidity (Clavein-Dindo grade III) was 4.2% and there was no postoperative mortality, which concurs with other studies. 39,43 In a systematic review, 30-day postoperative mortality ranged from 0% to 2.5%. 9 Thus, Pmet is a safe procedure in carefully selected patients.…”
Section: Discussionmentioning
confidence: 99%
“…Patients must have an adequate cardiopulmonary reserve. Pulmonary tumors should be completely resectable, and there should be adequate residual parenchyma . In the past, the extrapulmonary disease was also considered a contraindication to pulmonary metastasectomy, leaving only 1% to 2% of CRC patients with pulmonary metastases appropriate for surgical management .…”
Section: Defining Resectabilitymentioning
confidence: 99%
“…Pulmonary tumors should be completely resectable, and there should be adequate residual parenchyma. [12][13][14] In the past, the extrapulmonary disease was also considered a contraindication to pulmonary metastasectomy, leaving only 1% to 2% of CRC patients with pulmonary metastases appropriate for surgical management. 5 More recently, however, studies have suggested feasibility and overall benefit for resection of synchronous and potentially metachronous pulmonary and hepatic metastases.…”
Section: Defining Resectabilitymentioning
confidence: 99%
“…After Thomford et al [7] reported the principles of metastatic lung tumor resection in 1965, metastasectomy has been accepted by most surgeons as a potential curative option. Despite the development of novel chemotherapeutic and * Seok Tae Lim stlim@jbnu.ac.kr biologic agents, surgical resection is the most effective treatment for patients with pulmonary metastases [8]. While pulmonary resection for multiple or bilateral lesions remains controversial, the resection of solitary lung metastasis is generally accepted by physicians [9].…”
Section: Introductionmentioning
confidence: 99%